Diagnostic Imaging Services Market to Reach USD 134.50 Billion by 2035 at 4.80% CAGR

Diagnostic Imaging Services Market Overview

The Diagnostic Imaging Services Market is expanding as healthcare systems increasingly rely on advanced imaging for disease detection, screening, treatment planning, and ongoing patient monitoring. Rising chronic disease and aging populations, growing adoption of artificial intelligence, government investment in hospital infrastructure, and expanding reimbursement coverage for advanced imaging modalities are supporting market growth. The transition from analog to digital workflows and increasing demand for minimally invasive, image-guided procedures are also transforming imaging services.

According to the Market Research Future report updated August 24, 2026, the global Diagnostic Imaging Services Market was valued at USD 84.40 Billion in 2025 and is projected to grow from USD 88.20 Billion in 2026 to USD 134.50 Billion by 2035, registering a CAGR of 4.80% during 2026–2035. North America held the largest regional share at 44.90% in 2025, while Asia-Pacific is the fastest-growing region at a 5.95% CAGR. X-ray was the largest modality with a 26.50% share, Diagnostic Imaging accounted for 62.10% of applications, and Hospitals represented the largest end-user segment with a 56.50% share.

Unlock Exclusive Insights – Request Your Free Sample Report Now!

https://www.marketresearchfuture.com/sample_request/7186

Key players driving innovation and competitiveness in the Diagnostic Imaging Services Market include:

GE HealthCare

Siemens Healthineers

Philips Healthcare

Canon Medical Systems

Fujifilm Healthcare

Hologic

Carestream Health

Shimadzu Corporation

Samsung Healthcare

Mindray Medical

The market is being shaped by increasing demand for diagnostic procedures, advances in AI and machine learning, digital transformation, and the expansion of imaging infrastructure. AI-enabled workflows are improving image analysis and triage, while cloud-based PACS platforms are supporting multi-site image sharing and specialist access. The growing use of image-guided interventional procedures and theranostics is also expanding the role of diagnostic imaging beyond conventional disease detection.

The Diagnostic Imaging Services Market can be segmented by Procedure Type into X-ray, Ultrasound, Magnetic Resonance Imaging, Computed Tomography, and Nuclear Medicine. By End User, it includes Hospitals, Diagnostic Centers, Outpatient Imaging Centers, and Research Laboratories. By Imaging Modality, it covers Analog Imaging, Digital Imaging, and Hybrid Imaging. By Application, it includes Cardiology, Oncology, Neurology, and Orthopedics. Regionally, the market covers North America, Europe, South America, Asia Pacific, and the Middle East and Africa.

The growing demand for accessible, efficient, and technology-enabled imaging is creating opportunities for imaging service providers, diagnostic centers, healthcare networks, equipment manufacturers, AI developers, and healthcare IT companies. AI-powered autonomous imaging workflows, expansion into underserved Tier-2 and Tier-3 cities, imaging analytics, cloud-based PACS, and image-guided interventional procedures represent important areas of opportunity.

Recent Developments and Market Trends:

AI-powered imaging workflows are gaining momentum as healthcare providers use automated image analysis, triage, and reconstruction technologies to improve efficiency and support radiologists amid workforce shortages.

Computed tomography is emerging as the fastest-growing major modality, supported by faster scanner architectures and AI-assisted detection, while X-ray remains the largest modality because of its high-volume use in emergency, orthopedic, and chest imaging.

Cloud-based PACS and imaging analytics platforms are expanding as providers seek centralized image access, lower IT overhead, multi-site collaboration, and new analytics-based revenue opportunities.

Therapeutic and interventional imaging is gaining importance as healthcare moves toward minimally invasive procedures, including image-guided cardiac interventions, tumor ablation, and neurovascular procedures. The segment is projected to grow at a 7.10% CAGR through 2035.

Recent industry developments include GE HealthCare’s January 2025 launch of the Revolution Apex Elite CT with deep-learning reconstruction, Siemens Healthineers’ October 2024 FDA clearance for AI-Rad Companion Chest CT 2.0, Fujifilm Healthcare’s Synapse Radiology AI platform expansion, and RadNet’s June 2024 acquisition of 18 imaging centers.

Reasons to Buy the Report:

Provides comprehensive insights into the Diagnostic Imaging Services Market dynamics, trends, opportunities, competitive landscape, and growth potential.

Helps identify opportunities across X-ray, ultrasound, MRI, CT, nuclear medicine, and advanced imaging services.

Offers detailed segmentation analysis across procedure type, end user, imaging modality, application, and regional markets.

Includes competitive intelligence covering leading diagnostic imaging equipment, healthcare technology, imaging service, and AI companies.

Supports informed decisions using market forecasts, AI adoption, infrastructure investment, aging-population trends, reimbursement developments, interventional imaging growth, and regional opportunities.

Future Outlook:

The future of the Diagnostic Imaging Services Market will be shaped by aging populations, rising chronic disease prevalence, AI-enabled workflows, digital transformation, expanding healthcare infrastructure, and the shift toward minimally invasive image-guided procedures. X-ray should remain the largest modality, while Computed Tomography is positioned for the fastest growth among major modalities. Diagnostic Imaging should continue to dominate applications, although therapeutic and interventional imaging is expected to expand rapidly. Hospitals should remain the largest end-user setting, while Diagnostic Imaging Centers are projected to record faster growth as healthcare systems and payers increasingly emphasize cost-efficient outpatient care. North America should retain market leadership, while Asia-Pacific is expected to remain the fastest-growing region. Market Research Future projects the market to reach USD 134.50 Billion by 2035 at a CAGR of 4.80% during 2026–2035.

➤➤Explore Our Latest Related Reports:

Taurodontism Treatment Market
Peyronies Disease Treatment Market
Phelan McDermid Syndrome Market
Pingueculum Drug Market
Urine Test Strip Market
Serine Protease Assay Market
Sleeve Gastrectomy Device Market
Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresi Market
Trace Oxygen Analyzer Market
Puerperal Sepsis Treatment Market
Sertraline Market
Shigellosis Gastroenteritis Treatment Market
Skeletal Complications Treatment Market
Spasmodic Dysphonia Treatment Market
Tarlov Cyst Market

Written by

Market Research Future

Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis regarding diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Leave a Comment